Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hypoglycemic Agents in Chronic Hepatitis C Patients Receiving Peg-IFN/RBV
NCT01025765Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose, metformin, pioglitazone in hepatitis C (HCV), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
acarbosemetforminpioglitazone
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01025765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025765.